文献速递肝病

转氨酶正常的NAFLD患者中晚期纤维化与肝硬化的组织学表现

Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

该研究评估了534例经活检证实NAFLD且ALT、AST<40U/L的成人,发现NASH F2-F3和肝硬化的患病率分别为19%和7%。多因素模型预测NASH F2-F3的AUC为0.70,预测肝硬化为0.85,有助于排除晚期组织学改变。

要点

  • 转氨酶正常的NAFLD患者中仍可观察到NASH F2-F3(19%)和肝硬化(7%)。
  • 基于临床变量的模型对肝硬化有较高排除价值(阴性预测值98%)。
  • 预测模型可辅助临床医生在转氨酶正常的NAFLD患者中排除晚期肝病。

核心结论

  • 转氨酶正常的NAFLD患者中存在有临床意义的组织学表型,包括NASH F2-F3和肝硬化。
  • 基于临床变量的预测模型有助于排除晚期肝组织学改变。

研究设计与样本

  • 研究纳入534例经活检证实NAFLD且ALT和AST<40U/L的成人。
  • 采用多因素logistic回归(基于AIC)识别与NASH F2-F3及肝硬化相关的变量,并建立和内部验证临床预测模型。

主要发现

  • NASH F2-F3的患病率为19%,肝硬化的患病率为7%。
  • 预测NASH F2-F3的模型AUC为0.70(95%CI:0.65-0.76),预测肝硬化的模型AUC为0.85(95%CI:0.77-0.92)。
  • 在最大约登指数固定时,NASH F2-F3的阳性预测值为35%、阴性预测值为88%;肝硬化的阳性预测值为30%、阴性预测值为98%。

关键数值与推荐

  • NASH F2-F3的最佳AIC模型包含:2型糖尿病、白种人、较低LDL、较低血小板计数、较高AST/ALT比值、较高血清甘油三酯、高血压。
  • 肝硬化的最佳AIC模型包含:较低血小板计数、较低AST/ALT比值、较高BMI、女性。

临床怎么用

  • 对于转氨酶正常的NAFLD患者,应意识到仍可能存在晚期纤维化或肝硬化。
  • 所建模型可辅助临床医生排除晚期肝组织学改变,尤其是肝硬化(阴性预测值98%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with nonalcoholic fatty liver disease (NAFLD) and normal aminotransferase levels may have advanced liver histology. We conducted a study to characterize the prevalence of and factors associated with advanced liver histology in patients with histologically characterized NAFLD and normal aminotransferase levels. METHODS: We evaluated 534 adults with biopsy-proven NAFLD and alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <40U/L within 3 months of their liver biopsy. Histological phenotypes of primary interest were nonalcoholic steatohepatitis (NASH) with stage 2-3 fibrosis (NASH F2-3) and cirrhosis. Using multiple logistic regression models with Akaike's Information Criteria (AIC), we identified variables associated with these histological phenotypes. We developed and internally validated their clinical prediction models. RESULTS: The prevalence of NASH F2-F3 and cirrhosis was 19% and 7%, respectively. The best multiple regression AIC model for NASH F2-3 consisted of type 2 diabetes, white race, lower low-density lipoprotein, lower platelet count, higher AST/ALT ratio, higher serum triglycerides, and hypertension. The best AIC model for cirrhosis consisted of lower platelet count, lower AST/ALT ratio, higher body mass index, and female sex. The area under the receiver operator curves of the prediction models were 0.70 (95% confidence interval: 0.65-0.76) for detecting NASH-F2-3 and 0.85 (95% confidence interval: 0.77-0.92) for detecting cirrhosis. When models were fixed at maximum Youden's index, their positive and negative predictive values were 35% and 88% for NASH F2-F3 and 30% and 98% for cirrhosis, respectively. DISCUSSION: Clinically significant histological phenotypes are observed in patients with NAFLD and normal aminotransferase levels. Our models can assist the clinicians in excluding advanced liver histology in NAFLD patients with normal aminotransferase levels.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gawrieh S, Wilson LA, Cummings OW, et al. Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels. Am J Gastroenterol. 2019. PMID: 31517638. doi:10.14309/ajg.0000000000000388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。